Versant Ventures V, LLC - Jun 3, 2022 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
10%+ Owner
Signature
/s/ Robin L. Praeger, Managing Director of Versant Ventures V, LLC
Stock symbol
RPTX
Transactions as of
Jun 3, 2022
Transactions value $
-$9,188,775
Form type
4
Date filed
6/7/2022, 04:36 PM
Previous filing
Aug 9, 2021
Next filing
Jul 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Sale -$3.06M -250K -9.64% $12.25 2.34M Jun 3, 2022 See Footnote F1, F2
transaction RPTX Common Shares Sale -$5.38M -439K -23.05% $12.25 1.46M Jun 3, 2022 See Footnote F1, F3
transaction RPTX Common Shares Sale -$162K -13.2K -23.05% $12.25 44.1K Jun 3, 2022 See Footnote F1, F4
transaction RPTX Common Shares Sale -$179K -14.6K -23.05% $12.25 48.8K Jun 3, 2022 See Footnote F1, F5
transaction RPTX Common Shares Sale -$409K -33.4K -23.05% $12.25 111K Jun 3, 2022 See Footnote F1, F6
transaction RPTX Common Shares Other $0 -614K -41.94% $0.00 851K Jun 6, 2022 See Footnote F3, F7
transaction RPTX Common Shares Other $0 +133K $0.00 133K Jun 6, 2022 Direct F8, F9
transaction RPTX Common Shares Other $0 -18.5K -41.93% $0.00 25.6K Jun 6, 2022 See Footnote F4, F10
transaction RPTX Common Shares Other $0 +3.99K +3.01% $0.00 137K Jun 6, 2022 Direct F9, F11
transaction RPTX Common Shares Other $0 -20.5K -41.93% $0.00 28.3K Jun 6, 2022 See Footnote F5, F12
transaction RPTX Common Shares Other $0 +4.42K +3.23% $0.00 141K Jun 6, 2022 Direct F9, F13
transaction RPTX Common Shares Other $0 -141K -100% $0.00* 0 Jun 6, 2022 Direct F9, F14
transaction RPTX Common Shares Other $0 -46.8K -41.94% $0.00 64.7K Jun 6, 2022 See Footnote F6, F15
transaction RPTX Common Shares Other $0 +10.1K $0.00 10.1K Jun 6, 2022 See Footnote F16, F17
transaction RPTX Common Shares Other $0 -10.1K -100% $0.00* 0 Jun 6, 2022 See Footnote F17, F18
holding RPTX Common Shares 231K Jun 3, 2022 See Footnote F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Versant Ventures V, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F2 Shares held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
F3 Shares held by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
F4 Shares held by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
F5 Shares held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOAF I"). VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
F6 Shares held by Versant Venture Capital V (Canada) LP ("VVC V (Canada)"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
F7 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V to its partners.
F8 Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V.
F9 Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
F10 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VAF V to its partners.
F11 Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VAF V.
F12 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VOAF I to its partners.
F13 Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VOAF I.
F14 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V, to its members.
F15 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V (Canada) to its partners.
F16 Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada).
F17 Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
F18 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners.
F19 Shares held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.

Remarks:

1 of 2: Since there are 13 joint filers and EDGAR will not allow for entry of more than 10 joint filers, this Form 4 is being filed in conjunction with a Form 4 for Versant Vantage I, LP, Versant Vantage I GP, L.P. and Versant Vantage I GP-GP, LLC.